August 18, 2016—Most of the top 10 drugs that cost Medicare Part D the most in 2014 had double-digit price increases between 2013 and 2014, the Centers for Medicare & Medicaid Services reports. … [Read more...]
HRSA Releases 340B Dispute Resolution Proposed Rule
Comments due on or before Oct. 11August 11, 2016—The Health Resources and Services Administration has released its proposed regulation to create a binding administrative dispute resolution process for the 340B program. It will be formally published in the Federal Register tomorrow and comments will be due on or before Oct. 11. … [Read more...]
Report: Pharma Bankrolling Patients Groups in Part B Fight
Sheds light on reach of industry influenceA new report has found that patients’ groups fighting to block a controversial Part B demonstration project are overwhelmingly supported by the drug industry. … [Read more...]
OMB Clears 340B Dispute Resolution Proposed Rule
Could be published sooner than September targetAugust 4, 2016—The 340B program is another step closer to having a mandatory and binding administrative dispute resolution process. … [Read more...]
Don’t Report Best Prices Greater Than AMP, CMS Tells Drugmakers
If a manufacturer overstates best price, 340B overcharging is possibleAugust 4, 2016—Drug manufacturers have been reporting quarterly best prices for brand-name drugs to the Centers for Medicare & Medicaid Services higher than the same drugs' average manufacturer prices. … [Read more...]
Senator Wants to Know if Drugmakers Are Bilking Medicare Part D
Judiciary Committee Chairman Grassley asks CMS to investigateJuly 28, 2016—Senate Judiciary Chairman Charles Grassley (R-Iowa) wants the Centers for Medicare & Medicaid Services to investigate "an alarming trend in spending growth" in the catastrophic coverage portion of Medicare's prescription drug benefit, including whether drug companies might be exploiting the benefit. … [Read more...]
HRSA Seeing “Great Trends” in 340B Audits
Fewer issues of any sort are turning upJuly 19, 2016—Adverse findings in 340B covered entity audits are trending downward this year and the Health Resources and Services Administration is "comfortable" the direction will continue, the head of HRSA's Office of Pharmacy Affairs said at the largest annual gathering of 340B stakeholders. OPA Director Capt. Krista Pedley delivered the good news about 340B provider … [Read more...]